RT @MagnitudeBio: . @ELRIG_UK and @BritPharmSoc are hosting #TranslatingIdeas Into Therapies June 30, register & hear from @dweinkove on ho…Read More
RT @NETParkUK: Great to get a glimpse of the new @durham_uni Orbit Centre at #NETParkUK yesterday Orbit will house space for around 15 bus…Read More
RT @MunkleyLab: We are looking for a Research Technician to join our new spin-out Company GlycoScoreDx @DxGlycoRead More
RT @NETParkUK: 👏👏👏👏👏👏Congratulations to our first ever tenants @kromekgroup - incredible news and brilliant innovation with the potential t…Read More
RT @BiosphereNCL: Last chance to sign up to our @Bionow event tomorrow on Raising Investment! Hear from some of our North East life scien…Read More
Opportunities with @NewcellsBiotech, another fantastic @UniofNewcastle spin-out creating #moreandbetterjobs in the North EastRead More
RT @UniofNewcastle: From community and culture to enterprise and innovation, we are so proud to showcase our leading role in the economic a…Read More
RT @durham_uni: A student spinout company @spherauk is developing low carbon next generation construction materials. With help from @Nort…Read More
RT @hamish_mcalpine: Between this and things like @NorthGritstone, @Northern_Acc, @TheAMRC and many more, the potential of universities to…Read More
RT @dweinkove: Deadline on Friday for our C. elegans postRead More
To date we have
CEOs placed in start ups
Atelerix was the first Northern Accelerator spin-out, with CEO Dr Mick McLean recruited through the project’s ‘Execs into Business’ programme.
This Durham University spin-out is helping companies discover and develop new age-related treatments faster.
Healthcare experts and collaborators at Sunderland have been awarded funding of almost £50,000 from Northern Accelerator to develop a drug for the pre-clinical proof-of-concept stage over the next eight months
This innovative device could revolutionise the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19. To date, systems that diagnose from breath sampling have not proven to be reliable enough due to contamination, sample loss and variability issues.
gliff.ai is an innovative artificial intelligence (AI) company with ambitious plans to treble their staff headcount, expand into international export markets and secure multi-million-pound investment over the coming year.
Professor Kataky’s innovative work with biofilms to control the formation and spread of bacteria will make a real-world impact in the form of smart bandage technology. This can reduce reliance on antibiotics and improve patient outcomes, by reducing the risk of disease and infection when treating wounds.
Professor Che Connon is a serial academic entrepreneur, spinning out three companies from Newcastle University and bridging the gap between academia and private enterprise.
Growing up in North-Eastern Italy, Martina had a passion for STEM from a very young age.